August 7, 2019 / 9:37 PM / 7 months ago

Medicare to cover cancer CAR-Ts therapies

Aug 7 (Reuters) - The U.S. Centers for Medicare and Medicaid Services (CMS) finalized its decision to cover CAR-T cell therapies, the agency said on Wednesday.

CMS, which runs the federal government's healthcare plan for seniors, will cover the therapies when provided in certain healthcare facilities, the regulator said here

Chimeric antigen receptor T-cell therapy, known as CAR-T, involves drawing white blood cells from a patient, processing them in the lab to target cancer, and infusing the cells back into the patient. (Reporting by Ankur Banerjee in Bengaluru; Editing by Shinjini Ganguli)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below